Plecanatide · source year

Plecanatide research records in 2022

2 selected, source-linked Plecanatide records carrying a 2022 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

2 selected records.

Evidence types

1 represented type.

Cited sources

2 distinct public records.

Explore 2022 by evidence type

1 type

Cited chronology

Plecanatide records dated 2022

Open in the filterable feed →

June 2022

1 record

Literature metadata

Liquid-Phase Total Synthesis of Plecanatide Aided by Diphenylphosphinyloxyl Diphenyl Ketone (DDK) Derivatives.

PubMed lists PMID 32275447 in Organic letters as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-10 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

April 2022

1 record

Literature metadata

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.

PubMed lists PMID 28169285 in The American journal of gastroenterology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-02-07 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗